Video Back Videos home Signature collection Essentials collection Artificial Intelligence ...

Currently, few effective drugs are available for IPF ... The results were presented as the mean of duplicates in pictograms per ml. Total RNA was extracted from lung tissues with Trizol reagent ...

Stimulant medications are considered the first-line treatment for ADHD for some very good reasons. Here are 6 things to know about stimulant medications in ADHD. Attention Deficit Hyperactivity ...

Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the risks of substance abuse disorders, psychosis, infections, some kinds of ...

Weight-loss drugs like Ozempic may decrease your risk of developing 42 health conditions, but increase your chance of experiencing 19 others, according to one of the most comprehensive studies-of ...

Several disease-modifying therapies (DMTs) can help change the disease course of MS. People with MS can also take other medications for symptoms, complications, and relapses. Multiple sclerosis ...

(CNN) – The U.S. Food and Drug Administration approved the first new type of pain medication in more than two decades, and it’s not an opioid. The drug is suzetrigine under the brand name ...

Blockbuster obesity drugs such as Ozempic have been celebrated for their ability to promote weight loss and treat a surprising range of other conditions, from heart problems to Parkinson’s disease.

A major new analysis involving more than 130million people has revealed that five types of commonly taken medications could raise the risk of dementia. Antipsychotics, some medications for high ...

If you have high blood pressure, medication may be an important part of the plan to keep you healthy. Also called antihypertensive medicines, these drugs can't cure high blood pressure but can ...

Some of China’s senior doctors are raising concern over the quality of domestic generic medicines that have largely replaced western brand-name drugs at hospitals, amid a rare public backlash ...